Award details

Feasibility and Benchmarking of RiboTite gene expression control technology

ReferenceBB/J019089/1
Principal Investigator / Supervisor Professor Jason Micklefield
Co-Investigators /
Co-Supervisors
Dr Neil Dixon
Institution The University of Manchester
DepartmentChemistry
Funding typeResearch
Value (£) 146,160
StatusCompleted
TypeResearch Grant
Start date 18/06/2012
End date 17/09/2013
Duration15 months

Abstract

unavailable

Summary

We have developed a novel gene expression technology that has applications in the R&D kits market and in the manufacture of biopharmaceuticals. We plan through this current study to benchmark our expression technology against those systems currently available in the marketplace. This study will showcase the key areas of technical superiority of our technology, inform its subsequent positioning in the market place, inform our business planning and act as an enabling primer for private equity investment. The outputs from this grant will lead to partnering collaborations with industry, provide impact for BBSRC funded research, and potentially lead to wealth generation and job creation for the UK.
Committee Not funded via Committee
Research TopicsIndustrial Biotechnology, Pharmaceuticals, Technology and Methods Development
Research PriorityX – Research Priority information not available
Research Initiative Follow-On Fund (FOF) [2004-2015]
Funding SchemeX – not Funded via a specific Funding Scheme
terms and conditions of use (opens in new window)
export PDF file